Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
12.01B | 12.14B | 12.55B | 15.79B | 11.78B | 7.50B | Gross Profit |
1.69B | 1.96B | 2.22B | 4.07B | 3.50B | 1.02B | EBIT |
624.00M | 875.00M | 729.00M | 3.05B | 2.80B | 429.00M | EBITDA |
1.90B | 2.21B | 1.96B | 4.18B | 3.69B | 1.25B | Net Income Common Stockholders |
388.00M | 602.00M | 479.00M | 2.25B | 2.02B | 330.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.23B | 2.92B | 3.30B | 2.23B | 1.91B | 1.31B | Total Assets |
20.55B | 20.75B | 21.04B | 20.55B | 18.46B | 13.84B | Total Debt |
4.88B | 5.28B | 5.52B | 4.88B | 5.18B | 3.57B | Net Debt |
2.65B | 2.36B | 2.21B | 2.65B | 3.27B | 2.25B | Total Liabilities |
10.09B | 9.71B | 10.27B | 10.09B | 9.93B | 7.26B | Stockholders Equity |
9.93B | 10.53B | 10.24B | 9.93B | 7.96B | 6.04B |
Cash Flow | Free Cash Flow | ||||
84.00M | 306.00M | 1.30B | 2.29B | 1.74B | 772.00M | Operating Cash Flow |
1.07B | 1.31B | 2.34B | 3.40B | 2.39B | 1.30B | Investing Cash Flow |
-1.16B | -1.00B | -1.04B | -2.48B | -3.21B | -509.00M | Financing Cash Flow |
-691.00M | -650.00M | -245.00M | -587.00M | 1.44B | -216.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $3.35B | 33.83 | 4.32% | 2.89% | 3.58% | -5.17% | |
72 Outperform | $14.83B | 22.96 | 25.53% | 1.72% | -0.61% | 15.06% | |
67 Neutral | $9.29B | 10.25 | 16.16% | 4.06% | 2.78% | 1.50% | |
65 Neutral | $17.90B | 17.23 | 7.19% | 9.57% | -6.53% | -50.08% | |
56 Neutral | $9.17B | 24.04 | 3.71% | 2.91% | -1.27% | 48.34% | |
51 Neutral | $2.02B | -1.12 | -21.36% | 3.65% | 2.87% | -30.54% | |
48 Neutral | $8.67B | 15.18 | 12.17% | 0.47% | -28.74% | 53.25% |
At the 2025 Annual Meeting held on May 8, 2025, Westlake Corporation’s stockholders voted on two key matters. The election of four board members and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, were both approved, indicating continued stability and oversight in the company’s governance and financial auditing processes.
The most recent analyst rating on (WLK) stock is a Hold with a $110.00 price target. To see the full list of analyst forecasts on Westlake Chemical stock, see the WLK Stock Forecast page.
Westlake Corporation, a major player in the chemical industry, reported its financial results for the first quarter of 2025, revealing a challenging period with a net loss of $40 million and a decrease in EBITDA margin to 10%. The company’s Housing and Infrastructure Products segment showed resilience with a 20% EBITDA margin, while the Performance and Essential Materials segment faced difficulties, contributing to the overall operational loss.
On April 11, 2025, Westlake Corporation’s Board of Directors approved a special award of restricted stock units (RSUs) valued at $1,500,000 for Robert F. Buesinger, Executive Vice President of the Performance and Essential Materials Segment. The RSUs will fully vest on December 31, 2026, contingent upon Mr. Buesinger’s continued full-time employment with the company, highlighting the company’s commitment to retaining key leadership and potentially impacting its strategic direction.